Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients

Machet, L.; Nemeth-Normand, F.; Giraudeau, Bruno; Perrinaud, A.; Tiguemounine, J.; Ayoub, Jean; Alison, D.; Vaillant, L.; Lorette, G.

doi:10.1111/j.1365-2133.2004.06262.x

Cited by 59 publications

(34 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is often necessary to visualise sub-centimeter lesions or even smaller, as in the case when measuring the thickness of a melanoma, and this cannot be achieved using traditional 7-10 MHz ultrasound. However, such techniques are useful in dermatology, especially in detecting lymph node spread of melanoma (6,13,14). Other techniques such as optical coherence tomography and confocal microscopy are now available, with better resolution than 20-100 MHz ultrasound.…”

Section: Introductionmentioning

confidence: 99%

High Resolution Ultrasound Imaging of Melanocytic and Other Pigmented Lesions of the Skin

Machet¹,

Samimi²,

Georgesco³

et al. 2011

Ultrasound Imaging

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

High Resolution Ultrasound Imaging of Melanocytic and Other Pigmented Lesions of the Skin

Machet¹,

Samimi²,

Georgesco³

et al. 2011

Ultrasound Imaging

View full text Add to dashboard Cite

“…However, they concluded that the role of US in routine follow-up is still questionable since only a very small proportion of patients (1.3%) benefited from adding US to clinical examination. A large prospective randomized clinical trial would be needed to study the efficacy of US (29).…”

Section: Lymph Node Ultrasonographymentioning

confidence: 99%

Short-Term and Long-Term Management of Melanoma

Goel

Ward

et al. 2017

Cutaneous Melanoma: Etiology and Therapy

View full text Add to dashboard Cite

Without consensus guidelines for surveillance in patients with resected melanoma, much debate exists on the appropriate short-term and long-term management of melanoma. When discussing surveillance, it is also important to keep in mind the long-term impact of ongoing surveillance in terms of improved survival, patient quality of life, cost effectiveness, and exposure to risks associated with certain surveillance methods. Most studies recommend frequent follow-up visits with dermatologic surveillance to detect potentially curable recurrence, especially resectable locoregional recurrences. Surveillance laboratory tests and chest x-rays (CXR) can have limited value while producing a relatively high falsepositive rate. Lymph node ultrasonography is a valuable imaging modality in patients with equivocal lymphatic nodal basin physical examinations. In patients with early stages of melanoma, the benefit of routine surveillance imaging studies is questionable; however, close surveillance with detailed medical history and physical examination is necessary, with special attention to regional recurrences every 3-12 months, depending on the American Joint Committee on Cancer (AJCC) stage category the patient falls into and the risk of recurrence. In Stage III or greater, more frequent surveillance in the form of more frequent physical examination, laboratory tests based on symptomatology, and cross-sectional imaging 162may be indicated because of the higher risk of recurrence in this population. CT, MRI, and/or PET/CT are often a component of the overall follow-up for these high-risk patients. Additional studies are needed to better define the role of surveillance in the asymptomatic patient with resected melanoma.

show abstract

“…A meta-ana lysis by Bafounta et al, as well as another French study, showed that ultrasonography is more accurate in detecting lymph node metastasis than palpation; however, a benefit for the patient could not be established [58,59]. Schäfer-Hestenberg and colleagues concluded that frequent routine lymph node ultra sonography leads to earlier detection of nodal metastases and seems to prolong patient survival [60].…”

Section: Routine Additional Testing In Follow-upmentioning

confidence: 99%